European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Inossia Cement Softener - a new and unique additive to bone cements to revolutionise the treatment of vertebral fractures in osteoporotic patients

Objetivo

The Inossia Cement Softener is an additive (a softener) for bone cements that lowers their stiffness by 50-75% and adjusts it to that of the bone it is injected into. This does not alter the spinal biomechanics to the extent that the currently used cements do which in turn reduces the risk of new unnecessary vertebral fractures by 75%.
The Inossia Cement Softener has the potential to become a true game-changer and revolutionise the outcome of vertebral augmentation treatments in osteoporotic patients:

the patients will experience immediate pain relief, allowing them to go back to everyday life without the risk of rehospitalization,
the clinicians will be able to offer an efficient treatment
the healthcare payers will save money previously unnecessary spent on the retreatment of already treated patients

Our innovation is designed to revolutionise the treatment of osteoporosis, ensuring a healthy and active ageing.

Coordinador

INOSSIA AB
Aportación neta de la UEn
€ 2 298 325,00
Dirección
IOFFICE KUNGSGATAN 64
111 22 Stockholm
Suecia

Ver en el mapa

Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.

Región
Östra Sverige Stockholm Stockholms län
Enlaces
Coste total
€ 3 283 325,25